(a) Characteristics of CLL patients and control group. (b) Percentages of plasmablasts and serum anti-pneumococcal antibody as well as IgG2 levels before and after PCV13 vaccination in the CLL patients and control group.
收藏NIAID Data Ecosystem2026-03-09 收录
下载链接：
https://figshare.com/articles/dataset/_a_Characteristics_of_CLL_patients_and_control_group_b_Percentages_of_plasmablasts_and_serum_anti_pneumococcal_antibody_as_well_as_IgG2_levels_before_and_after_PCV13_vaccination_in_the_CLL_patients_and_control_group_/1271223
下载链接
链接失效反馈官方服务：
资源简介：
(a) Characteristics of CLL patients and control group. (b) Percentages of plasmablasts and serum anti-pneumococcal antibody as well as IgG2 levels before and after PCV13 vaccination in the CLL patients and control group.
创建时间：
2014-12-15
